Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 245

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 245
---
 Series B Warrants. The Private Placement closed on September 5, 2024, generating
net proceeds to the Company of $, after deducting placement agent fees and offering expenses.

The September 2024 Pre-Funded Warrants have an
exercise price of $ per share and are immediately exercisable, subject to certain ownership restrictions, and will remain exercisable
until exercised in full. The Series A and Series B Warrants have an exercise price of $ per share and will be exercisable beginning
on the effective date of stockholder approval to approve the exercise of the Series A and Series B Warrants and the September 2024 Agent
Warrants, defined below, to comply with applicable listing rules and regulations of the Nasdaq Stock Market (“Stockholder Approval”,
and such date that approval is obtained, the “Stockholder Approval Date”). The Series A Warrants expire five years after the
Stockholder Approval Date and the Series B Warrants will expire 18 months after the Stockholder Approval Date.

As compensation for acting as the placement agent
for the Private Placement, the Company issued to H.C. Wainwright & Co., LLC warrants to purchase up to shares of stock (the
“September 2024 Agent Warrants”). The September 2024 Agent Warrants have substantially the same terms as the Series A Warrants,
except that the September 2024 Agent Warrants have an exercise price equal to $ per share.

The following table presents a summary of the
activity for the Company’s equity-classified warrants during the three and nine months ended September 30, 2023:

| Total outstanding, December 31, 2022     
 Total outstanding, March 31, 2023        |     | Number of 
 Warrants  |       - 
       - |   |     | Weighted 
 Average  
 Exercise 
 Price    |     - 
     - |     | Weighted     
 Average      
 Remaining    
 Contractual  
 Life (Years) |    - 
    - |
|:-----------------------------------------|:----|:----------|--------:|:--|:----|:---------|------:|:----|:-------------|-----:|
| Total outstanding, June 30, 2023         |     |           |       - |   |     | $        |     - |     |              |    - |
| Reclassified from derivative liabilities |     |           |  19,330 |   |     |          | 65.58 |     |